{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T13:40:23Z","timestamp":1786282823410,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10620-024-08786-y","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T21:16:37Z","timestamp":1733951797000},"page":"191-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serotoninergic Mechanisms of Action in the Relaxant Properties of Saccharomyces boulardii CNCM I-745 on the Intestine"],"prefix":"10.1007","volume":"70","author":[{"given":"P.","family":"Girard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Verleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Castagn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"8786_CR1","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/microorganisms11040906","volume":"11","author":"F Maillard","year":"2023","unstructured":"Maillard F, Meynier M, Mondot S, et al. From In Vitro to In Vivo: A Rational Flowchart for the Selection and Characterization of Candidate Probiotic Strains in Intestinal Disorders. Microorganisms 2023;11:906.","journal-title":"Microorganisms"},{"key":"8786_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.729346","volume":"11","author":"L Xiao","year":"2021","unstructured":"Xiao L, Liu Q, Luo M, Xiong L. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome. Front Cell Infect Microbiol 2021;11:729346.","journal-title":"Front Cell Infect Microbiol"},{"key":"8786_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/1751-2980.13204","volume":"24","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Zou DW. Gut microbiota and irritable bowel syndrome. J Dig Dis 2023;24:312\u2013320.","journal-title":"J Dig Dis"},{"key":"8786_CR4","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3390\/molecules27051680","volume":"27","author":"T Guzel","year":"2022","unstructured":"Guzel T, Mirowska-Guzel D. The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy. Molecules 2022;27:1680.","journal-title":"Molecules"},{"key":"8786_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrgastro.2013.105","volume":"10","author":"GM Mawe","year":"2013","unstructured":"Mawe GM, Hoffman JM. Serotonin signalling in the gut\u2013functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol 2013;10:473\u2013486.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8786_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00210-008-0276-9","volume":"377","author":"DT Beattie","year":"2008","unstructured":"Beattie DT, Smith JAM. Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol 2008;377:181\u2013203.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"8786_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1365-2036.1999.00002.x-i2","volume":"13","author":"MD Gershon","year":"1999","unstructured":"Gershon MD. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999;13:15\u201330.","journal-title":"Aliment Pharmacol Ther"},{"key":"8786_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0166-4328(96)00075-7","volume":"73","author":"K Rack\u00e9","year":"1996","unstructured":"Rack\u00e9 K, Reimann A, Schw\u00f6rer H, Kilbinger H. Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 1996;73:83\u201387.","journal-title":"Behav Brain Res"},{"key":"8786_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1476-5381.2009.00155.x","volume":"158","author":"AK Bassil","year":"2009","unstructured":"Bassil AK, Taylor CM, Bolton VJN, Gray KM. Inhibition of colonic motility and defecation by RS-127445 suggests an involvement of the 5-HT2B receptor in rodent large bowel physiology. Br J Pharmacol 2009;158:252\u2013258.","journal-title":"Br J Pharmacol"},{"key":"8786_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejphar.2017.12.051","volume":"821","author":"FA Javid","year":"2018","unstructured":"Javid FA, Afshin-Javid S, Horn CC. Further investigation of the effects of 5-hydroxytryptamine, 8-OH-DPAT and DOI to mediate contraction and relaxation responses in the intestine and emesis in Suncus murinus. Eur J Pharmacol 2018;821:79\u201387.","journal-title":"Eur J Pharmacol"},{"key":"8786_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14026","volume":"33","author":"JR Konen","year":"2021","unstructured":"Konen JR, Haag MM, Guseva D, et al. Prokinetic actions of luminally acting 5-HT(4) receptor agonists. Neurogastroenterol Motil 2021;33:e14026.","journal-title":"Neurogastroenterol Motil"},{"key":"8786_CR12","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.3748\/wjg.v19.i39.6604","volume":"19","author":"H Morita","year":"2013","unstructured":"Morita H, Mochiki E, Takahashi N, et al. Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs. World J Gastroenterol 2013;19:6604\u20136612.","journal-title":"World J Gastroenterol"},{"key":"8786_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cca.2009.01.028","volume":"403","author":"A Sikander","year":"2009","unstructured":"Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clin Chim Acta 2009;403:47\u201355.","journal-title":"Clin Chim Acta"},{"key":"8786_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1365-2036.1999.00003.x-i2","volume":"13","author":"PP Humphrey","year":"1999","unstructured":"Humphrey PP, Bountra C, Clayton N, Kozlowski K. Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1999;13:31\u201338.","journal-title":"Aliment Pharmacol Ther"},{"key":"8786_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/apt.15420","volume":"50","author":"D Gunn","year":"2019","unstructured":"Gunn D, Garsed K, Lam C, et al. Abnormalities of mucosal serotonin metabolism and 5-HT(3) receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron. Aliment Pharmacol Ther 2019;50:538\u2013546.","journal-title":"Aliment Pharmacol Ther"},{"key":"8786_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.chom.2018.05.004","volume":"23","author":"Y Bhattarai","year":"2018","unstructured":"Bhattarai Y, Williams BB, Battaglioli EJ, et al. Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion. Cell Host Microbe 2018;23:775-785.e5.","journal-title":"Cell Host Microbe"},{"key":"8786_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jand.2019.05.015","volume":"120","author":"L Wang","year":"2020","unstructured":"Wang L, Alammar N, Singh R, et al. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. J Acad Nutr Diet 2020;120:565\u2013586.","journal-title":"J Acad Nutr Diet"},{"key":"8786_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14346","volume":"34","author":"TB Legan","year":"2022","unstructured":"Legan TB, Lavoie B, Mawe GM. Direct and indirect mechanisms by which the gut microbiota influence host serotonin systems. Neurogastroenterol Motil 2022;34:e14346.","journal-title":"Neurogastroenterol Motil"},{"key":"8786_CR19","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.14309\/ajg.0000000000001247","volume":"116","author":"VC Goodoory","year":"2021","unstructured":"Goodoory VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, Black CJ, Ford AC. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:1485\u20131494.","journal-title":"Am J Gastroenterol"},{"key":"8786_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14629","volume":"35","author":"TB Legan","year":"2023","unstructured":"Legan TB, Lavoie B, Norberg E, et al. Tryptophan-synthesizing bacteria enhance colonic motility. Neurogastroenterol Motil 2023;35:e14629.","journal-title":"Neurogastroenterol Motil"},{"key":"8786_CR21","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3748\/wjg.v16.i18.2202","volume":"16","author":"LV Mcfarland","year":"2010","unstructured":"Mcfarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 2010;16:2202\u20132222.","journal-title":"World J Gastroenterol"},{"key":"8786_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/apt.13344","volume":"42","author":"H Szajewska","year":"2015","unstructured":"Szajewska H, Ko\u0142odziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2015;42:793\u2013801.","journal-title":"Aliment Pharmacol Ther"},{"key":"8786_CR23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/apt.15659","volume":"51","author":"H Szajewska","year":"2020","unstructured":"Szajewska H, Ko\u0142odziej M, Zalewski BM. Systematic review with meta-analysis: Saccharomyces boulardii for treating acute gastroenteritis in children-a 2020 update. Aliment Pharmacol Ther 2020;51:678\u2013688.","journal-title":"Aliment Pharmacol Ther"},{"key":"8786_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13985","volume":"33","author":"M Constante","year":"2021","unstructured":"Constante M, de Palma G, Lu J, et al. Saccharomyces boulardii CNCM I-745 modulates the microbiota-gut-brain axis in a humanized mouse model of Irritable Bowel Syndrome. Neurogastroenterol Motil 2021;33:e13985.","journal-title":"Neurogastroenterol Motil"},{"key":"8786_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181863","volume":"12","author":"P Brun","year":"2017","unstructured":"Brun P, Scarpa M, Marchiori C,  et al. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS. PLoS One 2017;12:e0181863.","journal-title":"PLoS One"},{"key":"8786_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101154","volume":"41","author":"LV McFarland","year":"2021","unstructured":"McFarland LV, Karakan T, Karatas A. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. EClinicalMedicine 2021;41:101154.","journal-title":"EClinicalMedicine"},{"key":"8786_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106291","volume":"181","author":"Y Gu","year":"2022","unstructured":"Gu Y, Wang C, Qin X, et al. Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota. Pharmacol Res 2022;181:106291.","journal-title":"Pharmacol Res"},{"key":"8786_CR28","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/sj.bjp.0705762","volume":"141","author":"MD Crowell","year":"2004","unstructured":"Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol 2004;141:1285\u20131293.","journal-title":"Br J Pharmacol"},{"key":"8786_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1365-2982.1997.d01-62.x","volume":"9","author":"MR Briejer","year":"1997","unstructured":"Briejer MR. 5-HT receptor types in the rat ileum longitudinal muscle: focus on 5-HT2 receptors mediating contraction. Neurogastroenterol Motility 1997;9:231\u2013237.","journal-title":"Neurogastroenterol Motility"},{"key":"8786_CR30","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1016\/j.bmc.2017.09.018","volume":"25","author":"F Fiorino","year":"2017","unstructured":"Fiorino F, Magli E, K\u0119dzierska E, et al. New 5-HT1A, 5HT2A and 5HT2C receptor ligands containing a picolinic nucleus: Synthesis, in vitro and in vivo pharmacological evaluation. Bioorg Med Chem 2017;25:5820\u20135837.","journal-title":"Bioorg Med Chem"},{"key":"8786_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/bdd.2510100403","volume":"10","author":"H Blehaut","year":"1989","unstructured":"Blehaut H, Massot J, Elmer GW, Levy RH. Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm. Drug Dispos. 1989;10:353\u2013364.","journal-title":"Biopharm. Drug Dispos."},{"key":"8786_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/13693786.2010.533203","volume":"49","author":"G Samonis","year":"2011","unstructured":"Samonis G, Falagas ME, Lionakis S, et al. Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut. Med. Mycol. 2011;49:395\u2013399.","journal-title":"Med. Mycol."},{"key":"8786_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","volume":"71","author":"D Hoyer","year":"2002","unstructured":"Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002;71:533\u2013554.","journal-title":"Pharmacol Biochem Behav"},{"key":"8786_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1365-2982.2006.00812.x","volume":"18","author":"GE Boeckxstaens","year":"2006","unstructured":"Boeckxstaens GE, Tytgat GN, Wajs E, et al. The influence of the novel 5-HT1A agonist R137696 on the proximal stomach function in healthy volunteers. Neurogastroenterol Motil 2006;18:919\u2013926.","journal-title":"Neurogastroenterol Motil"},{"key":"8786_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0306-3623(97)00096-7","volume":"30","author":"A Gelal","year":"1998","unstructured":"Gelal A, Guven H. Characterization of 5-HT receptors in rat proximal colon. Gen Pharmacol 1998;30:343\u2013346.","journal-title":"Gen Pharmacol"},{"key":"8786_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000331878","volume":"88","author":"SB Lobo","year":"2011","unstructured":"Lobo SB, Denyer M, Britland S, Javid FA. The involvement of the serotonergic transmission system in neonatal and adult rat ileum contractility varies with age. Pharmacology 2011;88:225\u2013232.","journal-title":"Pharmacology"},{"key":"8786_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0014-2999(95)00234-C","volume":"281","author":"EA Forster","year":"1995","unstructured":"Forster EA, Cliffe IA, Bill DJ, et al. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 1995;281:81\u201388.","journal-title":"Eur. J. Pharmacol."},{"key":"8786_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/10799898409042543","volume":"4","author":"G Engel","year":"1984","unstructured":"Engel G, Hoyer D, Kalkman HO, Wick MB. Identification of 5HT2-receptors on longitudinal muscle of the guinea pig ileum. J Recept Res 1984;4:113\u2013126.","journal-title":"J Recept Res"},{"key":"8786_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/164_2016_103","volume":"239","author":"N Terry","year":"2017","unstructured":"Terry N, Margolis KG. Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance. Handb. Exp. Pharmacol. 2017;239:319\u2013342.","journal-title":"Handb. Exp. Pharmacol."},{"key":"8786_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0021-5198(19)31385-X","volume":"74","author":"M Yamano","year":"1997","unstructured":"Yamano M, Ito H, Miyata K. Species differences in the 5-hydroxytryptamine-induced contraction in the isolated distal ileum. Jpn J Pharmacol 1997;74:267\u2013274.","journal-title":"Jpn J Pharmacol"},{"key":"8786_CR41","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.2174\/1389450119666171227225408","volume":"19","author":"A Binienda","year":"2018","unstructured":"Binienda A, Storr M, Fichna J, Salaga M. Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review. Curr Drug Targets 2018;19:1774\u20131781.","journal-title":"Curr Drug Targets"},{"key":"8786_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0014-2999(01)01087-1","volume":"423","author":"MR Briejer","year":"2001","unstructured":"Briejer MR, Bosmans JP, van Daele P, et al. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol 2001;423:71\u201383.","journal-title":"Eur J Pharmacol"},{"key":"8786_CR43","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1053\/j.gastro.2005.08.005","volume":"129","author":"M Tonini","year":"2005","unstructured":"Tonini M, Vicini R, Cervio E, et al. 5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology 2005;129:1557\u20131566.","journal-title":"Gastroenterology"},{"key":"8786_CR44","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/sj.bjp.0702762","volume":"128","author":"NH Prins","year":"1999","unstructured":"Prins NH, Briejer MR, van Bergen PJ, Akkermans LM, Schuurkes JA. Evidence for 5-HT7 receptors mediating relaxation of human colonic circular smooth muscle. Br J Pharmacol 1999;128:849\u2013852.","journal-title":"Br J Pharmacol"},{"key":"8786_CR45","volume":"15","author":"U Osman","year":"2023","unstructured":"Osman U, Latha Kumar A, Sadagopan A, Mahmoud A, Begg M, Tarhuni M.N,  Fotso M, Gonzalez NA, Sanivarapu RR: The Effects of Serotonin Receptor Type 7 Modulation on Bowel Sensitivity and Smooth Muscle Tone in Patients With Irritable Bowel Syndrome. Cureus 2023;15:e42532.","journal-title":"Cureus"},{"key":"8786_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1113\/jphysiol.1993.sp019891","volume":"471","author":"HM Cousins","year":"1993","unstructured":"Cousins HM, Edwards FR, Hirst GD, Wendt IR. Cholinergic neuromuscular transmission in the longitudinal muscle of the guinea-pig ileum. J Physiol 1993;471:61\u201386.","journal-title":"J Physiol"},{"key":"8786_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00210-013-0944-2","volume":"387","author":"Y Tanahashi","year":"2014","unstructured":"Tanahashi Y, Ichimura Y, Kimura K, et al. Cholinergic neuromuscular transmission mediated by interstitial cells of Cajal in the myenteric layer in mouse ileal longitudinal smooth muscles. Naunyn Schmiedebergs Arch Pharmacol 2014;387:377\u2013388.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"8786_CR48","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1073\/pnas.69.11.3287","volume":"69","author":"TP Lee","year":"1972","unstructured":"Lee TP, Kuo JF, Greengard P. Role of muscarinic cholinergic receptors in regulation of guanosine 3\u2019:5\u2019-cyclic monophosphate content in mammalian brain, heart muscle, and intestinal smooth muscle. Proc Natl Acad Sci U S A 1972;69:3287\u20133291.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8786_CR49","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1152\/physrev.1987.67.3.902","volume":"67","author":"J Gonella","year":"1987","unstructured":"Gonella J, Bouvier M, Blanquet F. Extrinsic nervous control of motility of small and large intestines and related sphincters. Physiol Rev 1987;67:902\u2013961.","journal-title":"Physiol Rev"},{"key":"8786_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/flgastro-2019-101298","volume":"12","author":"CJ Black","year":"2021","unstructured":"Black CJ, Ford AC. Best management of irritable bowel syndrome. Frontline Gastroenterol 2021;12:303\u2013315.","journal-title":"Frontline Gastroenterol"},{"key":"8786_CR51","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/apt.15001","volume":"48","author":"AC Ford","year":"2018","unstructured":"Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther 2018;48:1044\u20131060.","journal-title":"Aliment Pharmacol Ther"},{"key":"8786_CR52","doi-asserted-by":"publisher","first-page":"709","DOI":"10.20452\/pamw.16067","volume":"131","author":"S Bonetto","year":"2021","unstructured":"Bonetto S, Fagoonee S, Battaglia E, Grassini M, Saracco GM, Pellicano R. Recent advances in the treatment of irritable bowel syndrome. Pol Arch Intern Med 2021;131:709\u2013715.","journal-title":"Pol Arch Intern Med"},{"key":"8786_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2023.100721","volume":"99","author":"GM Ahlawat","year":"2023","unstructured":"Ahlawat GM, Singh PK. Methods of Determining Irritable Bowel Syndrome and Efficiency of Probiotics in Treatment: A Review. Curr Ther Res Clin Exp 2023;99:100721.","journal-title":"Curr Ther Res Clin Exp"},{"key":"8786_CR54","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1089\/jmf.2009.0210","volume":"13","author":"R Budriesi","year":"2010","unstructured":"Budriesi R, Ioan P, Micucci M, Micucci E, Limongelli V, Chiarini A. Stop Fitan: antispasmodic effect of natural extract of chestnut wood in guinea pig ileum and proximal colon smooth muscle. J Med Food 2010;13:1104\u20131110.","journal-title":"J Med Food"},{"key":"8786_CR55","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14390","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Ren H, Yuan F, Shao M, Luo H. The effects of Saccharomyces boulardii on rat colonic hypermotility induced by repeated water avoidance stress and the potential mechanism. PeerJ 2022;10:e14390.","journal-title":"PeerJ"},{"key":"8786_CR56","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1053\/j.gastro.2011.01.052","volume":"140","author":"S Foley","year":"2011","unstructured":"Foley S, Garsed K, Singh G,  et al. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology 2011;140:1434\u201343.e1.","journal-title":"Gastroenterology"},{"key":"8786_CR57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0889-8553(21)00552-5","volume":"20","author":"SF Phillips","year":"1991","unstructured":"Phillips SF, Camilleri M. The ileocecal area and the irritable bowel syndrome. Gastroenterol Clin North Am 1991;20:297\u2013311.","journal-title":"Gastroenterol Clin North Am"},{"key":"8786_CR58","first-page":"208","volume":"7","author":"JE Kellow","year":"1996","unstructured":"Kellow JE, Bennett E. Functional disorders of the small intestine. Semin Gastrointest Dis 1996;7:208\u2013216.","journal-title":"Semin Gastrointest Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08786-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08786-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08786-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T08:35:34Z","timestamp":1737707734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08786-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["8786"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08786-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}